Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 70.65% institutional investors, 3.48% insiders, and 25.87% retail investors. Ra capital management is the largest institutional shareholder, holding 15.23% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.65% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Protara Therapeutics	70.65%	3.48%	25.87%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	3.40M	15.23%	$17.95M
Janus henderson group	2.27M	10.17%	$11.94M
Opaleye management	1.82M	8.17%	$9.64M
Blackstone	1.68M	7.52%	$8.87M
Boxer capital	811.63K	7.11%	$1.69M
Velan capital investment management lp	1.58M	7.07%	$8.34M
Sio capital management	1.44M	6.44%	$7.59M
Integral health asset management	1.40M	6.27%	$7.39M
Vanguard group	1.36M	6.09%	$7.18M
Woodline partners lp	853.16K	3.82%	$4.50M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	1.58M	7.19%	$8.34M
Sio capital management	1.44M	2.14%	$7.59M
Opaleye management	1.82M	1.69%	$9.64M
Superstring capital management lp	360.00K	1.65%	$1.90M
5am venture management	800.00K	1.01%	$4.22M
Integral health asset management	1.40M	0.63%	$7.39M
Cvi	302.75K	0.54%	$629.71K
Stempoint capital lp	332.39K	0.44%	$1.76M
Ra capital management	3.40M	0.24%	$17.95M
Adar1 capital management	122.69K	0.13%	$647.80K

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	2.27M	0.01%	2.27M
Blackstone	1.68M	0.04%	1.68M
Ra capital management	3.40M	0.24%	1.50M
Sio capital management	1.44M	2.14%	1.44M
Integral health asset management	1.40M	0.63%	1.40M

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-2.25M
Toronto dominion bank	-	-	-2.09M
Stempoint capital lp	332.39K	0.44%	-610.46K
Armistice capital	-	-	-520.00K
Ikarian capital	-	-	-350.49K

New Positions

Holder	Shares	% Assets	Change	Value
Janus henderson group	2.27M	0.01%	2.27M	$11.94M
Blackstone	1.68M	0.04%	1.68M	$8.87M
Sio capital management	1.44M	2.14%	1.44M	$7.59M
Integral health asset management	1.40M	0.63%	1.40M	$7.39M
5am venture management	800.00K	1.01%	800.00K	$4.22M

Sold Out

Holder	Change
Qube research	-2.00
Jpmorgan chase	-22.00
Advisor group	-100.00
Acadian asset management	-6.31K
Wolverine trading	-10.70K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	64	-	28,759,849	-3.07%	70	0.40%	33	-26.67%	12	20.00%
Dec 31, 2024	12	-66.67%	2,074,529	-80.14%	9	0.42%	8	-55.56%	3	-57.14%
Sep 30, 2024	36	-14.29%	10,447,278	-0.02%	46	0.56%	18	-28.00%	7	-12.50%
Jun 30, 2024	42	7.69%	10,449,817	128.63%	91	5.62%	25	56.25%	8	-11.11%
Mar 31, 2024	39	21.88%	4,570,660	4.88%	40	2.73%	16	77.78%	9	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.02M	2.65%	-
Vanguard US Total Market Shares ETF	616.30K	1.74%	-
Vanguard Institutional Extnd Mkt Idx Tr	528.76K	1.37%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	125.00K	0.61%	-
Fidelity Extended Market Index	173.64K	0.45%	79.73K
BlackRock Extended Equity Market K	54.38K	0.26%	-23.00
Vifag 2002 SICAV	75.00K	0.21%	-
Fidelity Total Market Index	59.51K	0.15%	29.33K
Extended Equity Market Fund K	53.80K	0.15%	165.00
Avantis US Small Cap Equity ETF	54.46K	0.14%	648.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 14, 2025	Levy Richard S	-	Buy	$63.80K
Mar 26, 2025	Zummo Jacqueline	Chf Scientific Operations Off	Sell	$96.14K
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$2.74K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$204.73K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$11.11K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	1	-
2025 Q1	-	1
2024 Q3	-	18
2024 Q2	-	18
2024 Q1	-	-

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 70.65%, followed by 3.48% insiders and 25.87% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 63.96%, which Protara Therapeutics exceeds.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Ra capital management (3.4M shares, 15.23%), Janus henderson group (2.27M shares, 10.17%), and Opaleye management (1.82M shares, 8.17%). Together, they hold 33.57% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.19% of its assets in 1.58M Protara Therapeutics shares, valued at 8.34M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 2.65% of its total shares outstanding invested in 1.02M Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools